Zonguldak Karaelmas Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Zonguldak
Müjdat Kara
Trakya Üniversitesi Tıp Fakültesi, Endokrinoloji Bilim Dalı, Edirne, Turkey
Sema Yarman
Istanbul University Istanbul Faculty of Medicine, Department of Endocrinology and Metabolic Diseases, Istanbul, Turkey
Refik Tanakol
Istanbul University Istanbul Faculty of Medicine, Department of Endocrinology and Metabolic Diseases, Istanbul, Turkey
Faruk Alagöl
Istanbul University Istanbul Faculty of Medicine, Department of Endocrinology and Metabolic Diseases, Istanbul, Turkey
Bayraktaroğlu, T., Kara, M., Yarman, S., Tanakol, R., & Alagöl, F. (2006). Levothyroxine Replacement is Acceptable in Patients With Above the Upper Normal Range Lipid Profiles and Subclinical Hypothyroidism - Original Article. Endocrinology Research and Practice, 10(4), 0–0. Retrieved from https://endocrinolrespract.org/index.php/pub/article/view/413
Abstract Introduction: Subclinical hypothyroidism is a common disorder, particularly in middle-aged and elderly individuals. The aim of the present study was to determine the effect of L-thyroxine (LT4) substitution on serum lipid profile in patients with subclinical hypothyroidism (TSH > 4.5 μIU/mL and normal FT4). Materials and Methods: Thirty-six female patients (mean age, 39 ± 9 yrs) with Hashimoto's thyroiditis were recruited in this study. The patients were separated into two groups according to their baseline lipid levels: group I, total cholesterol (TC)> 200 mg/dl (n=18); group II, low-density lipoprotein cholesterol (LDLc) >130 mg/dl (n=17). Thyroid hormone levels and lipid parameters were measured at baseline and after euthyroidism (TSH < 2.5 μIU/mL) was achieved. Results: Despite the fact that lipid profiles were not different between baseline and euthyroid conditions, TC and LDL levels were decreased significantly when euthyroidism was achieved (p<0.05) provided that the patients were separated into two groups according to their baseline lipid levels. Discussion: TSH-guided LT4 therapy can improve lipid profile in patients with subclinical hypothyroidism if TC and/or LDLc levels were above the upper normal range.
Berrin Çetinarslan, İbrahim Demirci, Cem Haymana, Alev Selek, İlker Taşçı, Zeynep Cantürk, Taner Bayraktaroğlu, Serpil Salman, Canan Ersoy, Fahri Bayram, İlhan Satman, Alper Sönmez
Article Info
Published In
JournalEndocrinology Research and Practice
Volume / IssueVolume 10 · Issue 4
Pages0-0
History
Published OnlineDecember 1, 2006
Copyright
Copyright (c) 2006 Endocrinology Research and Practice
Affiliations
Taner Bayraktaroğlu
Zonguldak Karaelmas Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Zonguldak
Müjdat Kara
Trakya Üniversitesi Tıp Fakültesi, Endokrinoloji Bilim Dalı, Edirne, Turkey
Sema Yarman
Istanbul University Istanbul Faculty of Medicine, Department of Endocrinology and Metabolic Diseases, Istanbul, Turkey
Refik Tanakol
Istanbul University Istanbul Faculty of Medicine, Department of Endocrinology and Metabolic Diseases, Istanbul, Turkey
Faruk Alagöl
Istanbul University Istanbul Faculty of Medicine, Department of Endocrinology and Metabolic Diseases, Istanbul, Turkey
Cite this Article
Bayraktaroğlu, T., Kara, M., Yarman, S., Tanakol, R., & Alagöl, F. (2006). Levothyroxine Replacement is Acceptable in Patients With Above the Upper Normal Range Lipid Profiles and Subclinical Hypothyroidism - Original Article. Endocrinology Research and Practice, 10(4), 0–0. Retrieved from https://endocrinolrespract.org/index.php/pub/article/view/413